STOCK TITAN

BetterInvesting™ Magazine Update on Paychex Inc. and Pfizer Inc.

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine has named Paychex Inc. as its 'Stock to Study' and Pfizer Inc. as its 'Undervalued Stock' in the June/July 2024 issue. Ken Zendel, CEO of the National Association of Investors Inc., emphasizes the importance of focusing on company fundamentals like earnings amidst the Reddit IPO hype.
Positive
  • None.
Negative
  • None.

TROY, Mich., March 28, 2024 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Paychex Inc. (NYSE: PAYX) as its "Stock to Study" and Pfizer Inc. (NYSE: PFE) as its "Undervalued Stock" in the June/July 2024 issue for investors' informational and educational use.

"One of the top stock market stories of the week is the Reddit IPO. While IPOs are always headline-grabbing," said Ken Zendel, chief executive officer of the National Association of Investors Inc., publisher of BetterInvesting, "the BetterInvesting educators remind investors to focus on the fundamentals, such as earnings, of individual companies, whether by using the Stock Selection Guide® or by doing their homework via other methods."

Learn more about how to analyze companies and pick the best stocks at:
https://www.betterinvesting.org/learn-about-investing/investor-education/getting-started-with-stocks/how-to-pick-great-stocks

Check the June/July 2024 issue of BetterInvesting Magazine for more details about the latest stocks. Non-members can utilize the limited, trial version of the BetterInvesting online stock selection and analysis tools to study the investment potential of Paychex Inc. and Pfizer Inc. by viewing their fundamental data and applying judgments.

Committee members are Lauren Adams, CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Walter J. Kirchberger, CFA; Anne Nichols, CFA; and Dan Rutter, CFA.

As stated, the BetterInvesting committee's Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.  Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.

About BetterInvesting:

BetterInvesting™, a national 501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors™ (NAIC®), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting provides unbiased, in-depth investing education and powerful online stock analysis tools to create successful lifelong investors. BetterInvesting staff, along with a dedicated community of volunteers across America, teach the organization's principles and time-tested methodology to individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org

Follow us on LinkedIn and Facebook.

Contact: 877-275-6242

Cision View original content:https://www.prnewswire.com/news-releases/betterinvesting-magazine-update-on-paychex-inc-and-pfizer-inc-302103142.html

SOURCE NAIC-BetterInvesting

Paychex Inc. was selected as the 'Stock to Study' due to its strong fundamentals and potential for growth.

Pfizer Inc. was recognized as the 'Undervalued Stock' by BetterInvesting Magazine in the June/July 2024 issue.

Ken Zendel is the CEO of the National Association of Investors Inc.

Ken Zendel advised investors to focus on company fundamentals like earnings amidst the Reddit IPO hype.
Pfizer Inc.

NYSE:PFE

PFE Rankings

PFE Latest News

PFE Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Health Technology, Pharmaceuticals: Major, Manufacturing, Pharmaceutical Preparation Manufacturing
US
Palo Alto

About PFE

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.